ABSTRACT
INTRODUCTION

60
High energetic demand requires that the heart continuously generates ATP to sustain cardiac contractile 61 function (23, 25) . The heart uses several fuel substrates for energy metabolism (22, 24) , with fatty acid 62 oxidation (FAO) accounting for 50-70% of the total ATP generated (6, 20, 23) . While healthy hearts 63 have the flexibility to use various substrates, a shift towards increased fatty acid utilization is a key 64 feature of obesity and diabetes (21). Elevated levels of circulating free fatty acids and triacylglycerol, 65 combined with alterations in FAO enzyme abundance or activity, promote cardiomyocyte lipid 66 accumulation, cardiac dysfunction and heart failure (7, 9, 16, 40) . As the prevalence of obesity and 67 diabetes continues to increase, it is imperative that we examine the processes that regulate cardiac 68 energy metabolism under these conditions. activity by acetylation appears to be particularly important (2, 26, 29, 39, 41) . Mitochondrial protein 73 acetylation is significantly increased in various tissues during high fat diet feeding (14, 17) , and fatty 74 acids are the main source of the acetyl-CoA used as a co-factor for lysine acetylation (28). These data 75 imply that there is an intrinsic link between nutritional inputs, lysine acetylation and metabolic activity.
76
Taken together, changes in the acetylation status of cardiac FAO enzymes may greatly impact their 77 activity, and could be a key cellular mechanism that drives metabolic dysfunction in the hearts of obese 78 individuals.
79
The regulation of mitochondrial lysine acetylation has predominantly focused on the activity of 80 SIRT3, the major mitochondrial deacetylase enzyme (13, 14, 33) . SIRT3 has been shown to target a 81 number of different regulators of energy metabolism, including the FAO enzyme long-chain acyl-CoA 82 dehydrogenase (LCAD) (13, 14) , and the catalytic subunits of pyruvate dehydrogenase (PDHA) (15). In 83 many tissues the deacetylation of mitochondrial enzymes promotes their enzymatic function (4, 5, 14) ; 84 however there are contrasting reports in the heart (1, 8) which highlights the need for further study.
85
While there have been numerous reports on the regulation of mitochondrial lysine deacetylation, few 86 studies have addressed the counteracting process of lysine acetylation. In particular, the function of the 87 recently discovered mitochondrial acetyltransferase protein GCN5L1(35) in cardiac energy metabolism 88 has yet to be intensively explored.
89
GCN5L1 is localized in the mitochondrial matrix, and has been shown to counter the activity of the 90 mitochondrial deacetylase protein SIRT3 (35). Deletion of GCN5L1 blunts mitochondrial protein 91 acetylation and bioenergetics, which promotes mitochondrial dysfunction and cellular energy depletion 92 in mouse embryonic fibroblasts (34). In the current study, we examined the effect of long-term high fat 93 diet on the regulation of GCN5L1 and lysine acetylation in the heart. We show that nutrient excess 94 promotes increased mitochondrial lysine acetylation, which correlates with upregulated expression of 95 GCN5L1 at the expense of SIRT3. High fat feeding led to the hyperacetylation of mitochondrial FAO 96 proteins, which was associated with increased enzymatic activity in in vitro assays. Finally, we found 97 that knockdown of GCN5L1 reduced both the acetylation and activity of FAO enzymes, which 98 culminated in a reduction in mitochondrial bioenergetic output in cardiac-derived H9C2 cells. 
MATERIALS AND METHODS
102
Animal Care and Use
103
Male C57BL/6J mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and housed in the 
Protein Isolation
114
For whole cardiac protein lysate, tissues were minced and lysed in CHAPS buffer on ice for ~2 hours.
115
Homogenates were spun at 10,000 g, and the supernatants collected for western blotting or co-116 immunoprecipitation experiments. For mitochondrial assays, tissues were lysed in detergent-free buffer 117 and mitochondrial proteins were isolated using the QProteome Mitochondrial Isolation Kit (Qiagen) 118 using the manufacturer's protocol. For activity assays, muscle homogenates were prepared in a modified
119
Chappell-Perry Medium A buffer (120 mM KCl, 20mM Hepes, 5 mM MgCl 2 , 1 mM EGTA, pH~7.2) 120 supplemented with 5 mg/ml fat-free bovine serum albumin. After centrifugation at 10,000 g, 121 supernatants were used to assay enzyme activity. 
RNA Isolation and qRT-PCR
153
For qRT-PCR, mRNA was isolated using a total RNA extraction kit (Qiagen), and cDNA was produced 154 using a first-strand synthesis kit (Invitrogen). Transcript levels were measured using validated gene- 
Mitochondrial Bioenergetics Measurements
167
Oxygen Consumption Rate (OCR) was measured in GCN5L1 control and knockdown stable H9C2 cell 
Statistics
177
Means ± SEM were calculated for all data sets. Data were analyzed using two-tailed student's t-tests, 
RESULTS
184
Mitochondrial Fuel Metabolism Gene Expression is Modulated by HFD
185
Significant increases in heart mass were observed in animals following 24 weeks of HFD (Table 1 (41)). To further investigate how HFD controls mitochondrial acetylation in the heart, we first 202 examined the expression of two mitochondrial acetylation regulators, GCN5L1 and SIRT3. 
216
As exposure to a long-term HFD raises both circulating fatty acid and glucose levels, we next 217 aimed to determine which metabolic substrate was responsible for the elevated gene expression of Finally, our overall protein expression data from these acetylation regulators suggested a shift 228 towards a pro-acetylation phenotype. To test this, we isolated mitochondria from chow and HFD mice, 229 and examined the acetylation status of mitochondrial proteins using a pan-acetylation antibody. This 230 confirmed that there was indeed an increase in this modification in the heart following HFD (Figure 3) .
232
Hyperacetylated FAO Proteins from HFD Mice Show Increased Enzymatic Activity
233
The role of acetylation in regulating metabolic enzyme activity has been extensively studied in several 234 tissues, particularly the liver and skeletal muscle (13-15, 17, 18, 28, 41) . However, the role of this 235 modification in the heart remains to be fully elucidated. In an attempt to understand the effects of further exacerbate the switch to a pro-FAO metabolic phenotype in the obese heart. We next examined 244 whether HFD had any effect on FAO enzyme activity, and found that both SCAD and LCAD oxidation 245 rates were significantly upregulated in samples obtained from overfed mice (Figure 5A, B) . We 
Reductions in GCN5L1 Expression Limit Cellular FAO Activity
252
The observed differences in FAO enzymatic activities and mitochondrial protein acetylation, coupled 253 with a significant increase in GCN5L1 protein content in obese mice, led us to further examine the 254 regulatory role of GCN5L1 in cardiac mitochondrial bioenergetics. To aid these studies, we created 255 three stable GCN5L1 knockdown H9C2 cell lines using different lentiviral-delivered shRNAs. GCN5L1 256 mRNA levels and protein content were significantly decreased in two lines (KD1 and KD3) ( Figure 6A ) 257 which were then selected for further characterization. We first tested whether loss of GCN5L1 had any 258 effect on overall cellular fitness, and found that GCN5L1 depletion in H9C2 cells had no effect on 
GCN5L1 Knockdown Decreases Acetylation and Enzymatic Activity of FAO Proteins
270
Finally, we attempted to investigate whether there was a mechanistic link between GCN5L1-regulated 271 mitochondrial protein acetylation and FAO rates in H9C2 cells. Using our immunoprecipitation-based 272 acetylation assay, we found a large decrease in the acetylation status of both SCAD and LCAD in 273 GCN5L1 knockdown cells relative to the control (Figure 7 A, B) ; although no change in acetylation 274 level was seen in HADHA and PDH using the same methodology (data not shown). We then assessed 275 the activity of SCAD and LCAD in vitro, and found that loss of GCN5L1 significantly reduced the 276 oxidation capacity of both dehydrogenases (Figure 7 C, D) . From these studies, we conclude that 277 GCN5L1 promotes the acetylation of mitochondrial FAO proteins, and that this modification is strongly 278 associated with increased FAO activity in cardiac cells. GCN5L1 expression in the heart in both non-surgical (1) and surgical investigations of cardiac 315 metabolism (30). Our current findings are in direct contrast to a previous publication by Alrob et al., 316 which showed that GCN5L1 expression was not significantly changed in the heart following HFD (1).
317
Here we show that GCN5L1 is significantly upregulated at both the gene and protein level in HFD-318 exposed mice, and that high concentrations of both glucose and palmitate can upregulate Gcn5l1 319 expression in H9C2 cells. The contrasting findings may also explain why we found a significant increase 320 in PDH acetylation not observed previously (1). The reasons behind the diverse study outcomes are 321 currently unclear, although may be related to simple differences in diet composition (41% vs. 60% fat) 322 or study length (16-18 weeks vs. 24 weeks).
323
In addition to our findings on GCN5L1 regulation, we observed an interesting discrepancy 324 between SIRT3 gene and protein expression in our HFD animals. Numerous studies have shown that 325 SIRT3 protein abundance is decreased in response to a HFD, however there is little published 326 information on how Sirt3 gene expression is affected by nutrient excess. We show here that Sirt3 is 327 significantly upregulated in both HFD mouse hearts and in palmitate-treated H9C2 cells, while its 328 protein abundance is reduced in vivo under the same conditions (Figure 2) . The mechanism by which 329 the mitochondrial form of SIRT3 is reduced -despite unchanged levels of the pre-import cytosolic form 330 -remains to be determined, but may be linked to increased SIRT3 degradation under high fat 331 conditions. Overall, we conclude that regulators of both mitochondrial lysine acetylation and 332 deacetylation are closely controlled by nutrient availability, and that this system has evolved to regulate 333 mitochondrial bioenergetics in response to changing nutritional and physiological conditions.
334
We previously showed that GCN5L1 modulates the acetylation of electron transport chain 335 proteins (35), and its loss negatively impacts mitochondrial bioenergetic output (34). Here we focused 336 on the effect of GCN5L1 on FAO enzymes SCAD and LCAD, which oxidize short and long chain fatty 337 acids respectively. LCAD function is particularly important in maintaining cardiac bioenergetic output,
338
and loss of LCAD activity has been shown to result in an elevated reliance on glucose oxidation (3).
339
Conversely, increased activity of LCAD has been associated with increased FAO in the heart (1). We 340 found that SCAD and LCAD are hyperacetylated following a long-term HFD, and have increased 341 enzymatic activity in in vitro assays. As these changes correlated with an increase in GCN5L1 342 abundance, we investigated whether this protein had a functional effect on FAO enzyme activity.
343
Knockdown of GCN5L1 in our stable cardiac cell line resulted in decreased acetylation of SCAD and 344 LCAD, and significantly reduced the enzymatic activity of LCAD. Furthermore, we show for the first 345 time that reductions in GCN5L1 abundance lead to a significant decrease in cellular FAO rates. These 
351
The outcomes of the present study are in broad agreement with a very recent publication, which
352
showed that reduced GCN5L1 expression led to a significant decrease in the in vitro activity of LCAD 353 and β-HAD (11, 12). Importantly, this study also showed that GCN5L1 abundance increased during (27)), and it may be that each tissue uses acetylation to regulate 368 metabolic activity differently, even on a protein-by-protein basis. Given that the heart is particularly 369 reliant on FAO (21), and that fatty acids are the main source of acetyl-CoA for acetylation (28), it may 370 be logical that increases in fatty acid availability in the heart would not immediately downregulate FAO 371 via acetylation, as it does in other tissues. Future comparative studies, investigating the sites of lysine 372 acetylation on the same protein in different tissues, should help to answer some of these questions.
373
In conclusion, our findings in this study suggest that the regulation of lysine acetylation in 374 mitochondria plays a major role in controlling cardiac bioenergetic output, and that the utilization of 375 fatty acids in the heart is enhanced when increased nutrient availability promotes the acetylation of FAO Regression analysis showed a significant correlation between LCAD acetylation status and enzymatic 552 activity from all tested mice. Values are expressed as means ± SEM. P value significance is as shown in 553 the graphs using two-way student's t-test, n = 4 per group. value significance is as shown in the graphs, n = 4 per group for GCN5L1 mRNA and protein levels, n = 565 8 per group for respiration measurements. One-way ANOVA was used for Figure 6A , E-G, two-way 566 ANOVA was used for Figure 6B -C, Tukey post-hoc testing was performed in each case. 
573
P value significance is as shown in the graphs using two-way student's t-test, n = 4 per group. balance between lysine acetylation and deacetylation allows mitochondria to maintain bioenergetic 577 output under changing physiological conditions. In obese mice, increased acetylation of mitochondrial 578 proteins drives a pro-FAO metabolic phenotype, thereby reducing substrate flexibility in the heart.
